FINVASIA MUTUAL FUNDS

DSP Healthcare Fund - Direct (IDCW)

by:DSP Healthcare Fund

Invest

Statistics

  • AUM

    1195.58Cr

  • Returns

    1y : 56.78%
    3y : 20.35%
    5y : 34.02%
    Since Inception : 29.08%

  • NAV

    30.40 ( as on 17-09-2024)

  • Risk

    Very High

  • Last Dividend Paid

    1.90

  • Expense Ratio

    0.00%

  • Benchmark

    S&P BSE Healthcare TRI

  • Exit Load

    <= 12 months - 1%.

3m6m1y2yALL
Fund Manager Name
Vinit Sambre
Qualification
B.Com., FCA
Designation
FUND MANAGER
Experience
Prior to joining DSP BlackRock he was associated with DSP Merrill Lynch Ltd.(Nov 2005 to Jun 2007), IL & FS Investsmart Ltd. (Dec 2002 to Oct 2005), Unit Trust of India Investment Advisory Services Ltd.(Jun 2000 to Dec 2002), Kisan Ratilal Choksey Shares
Remarks

    Holdings

  • Company

    Sector

    Percentage held

  • Sun Pharma.Inds.

    Pharmaceuticals & Biotechnology

    12.59%

  • Cipla

    Pharmaceuticals & Biotechnology

    8.49%

  • Ipca Labs.

    Pharmaceuticals & Biotechnology

    7.82%

  • Suven Pharma

    Pharmaceuticals & Biotechnology

    7.56%

  • Lupin

    Pharmaceuticals & Biotechnology

    7.32%

  • Divi's Lab.

    Pharmaceuticals

    6.34%

  • Alembic Pharma

    Pharmaceuticals & Biotechnology

    5.56%

  • Globus Medical Inc

    Healthcare Equipment & Supplies

    5.51%

  • Apollo Hospitals

    Healthcare Services

    4.60%

  • Zydus Lifesci.

    Pharmaceuticals & Biotechnology

    4.39%

  • Dr Reddy's Labs

    Pharmaceuticals & Biotechnology

    4.04%

  • Suven Life Scie.

    Pharmaceuticals & Biotechnology

    3.92%

  • Torrent Pharma.

    Pharmaceuticals

    3.88%

  • Concord Biotech

    Pharmaceuticals & Biotechnology

    3.87%

  • Vijaya Diagnost.

    Healthcare Services

    3.51%

  • J B Chem & Pharm

    Pharmaceuticals

    3.28%

  • P & G Health Ltd

    Pharmaceuticals & Biotechnology

    3.16%

  • Dr Lal Pathlabs

    Healthcare

    3.06%

  • Alkem Lab

    Pharmaceuticals & Biotechnology

    2.97%

  • Kovai Medical

    Healthcare Services

    2.93%

  • Other Foreign Equity

    Healthcare Services

    2.75%

  • Intuitive Surgical

    Healthcare Services

    2.70%

  • Indoco Remedies

    Pharmaceuticals & Biotechnology

    2.66%

  • TREPS

    NA

    2.60%

  • Jubilant Life

    Pharmaceuticals

    2.33%

  • Abiomed Inc

    Healthcare Equipment & Supplies

    2.26%

  • Illumina Inc

    Healthcare Services

    1.93%

  • Syngene Intl.

    Healthcare Services

    1.82%

  • Unichem Labs.

    Pharmaceuticals & Biotechnology

    1.69%

  • ICICI Lombard

    Insurance

    1.61%

  • Max Healthcare

    Healthcare Services

    1.52%

  • Narayana Hrudaya

    Healthcare Services

    1.50%

  • ILLUMINA

    Pharmaceuticals

    1.50%

  • Aarti Drugs

    Pharmaceuticals & Biotechnology

    1.49%

  • Taro Pharmaceutical Industries

    Pharmaceuticals & Biotechnology

    1.35%

  • Abbott Laboratories

    Pharmaceuticals & Biotechnology

    1.14%

  • Abbott India

    Pharmaceuticals

    1.02%

  • Global X Funds - Global X Geno

    Foreign Security

    0.88%

  • Ajanta Pharma

    Pharmaceuticals

    0.87%

  • Medplus Health

    Retailing

    0.59%

  • Pfizer

    Pharmaceuticals & Biotechnology

    0.49%

  • Jupiter Life Lin

    Healthcare Services

    0.48%

  • Mankind Pharma

    Pharmaceuticals & Biotechnology

    0.44%

  • Max India Ltd

    Healthcare Services

    0.40%

  • Reverse Repo

    NA

    0.26%

  • Net CA & Others

    NA

    -1.35%

Scheme Objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there can be no assurance that the investment objective of the scheme will be realized.

AMC Details

  • Name

    DSP Investment Managers Private Ltd

  • Email Id

    service@dspim.com

  • Website Url

    www.dspim.com

  • Address

    Mafatlal Centre,10th Floor,Nariman Point, Mumbai 400 021.

  • Telephone Number

    022-66578000

  • Fax Number

    022-66578181

Fund Details

  • Scheme Type

    Dividend

  • Category

    Equity - Diversified

  • Launch Date

    2018-11-12

  • Fund Type

    Open-Ended

  • Fund Manager

    Vinit Sambre

  • Min. Investment (One Time)

    500

  • Min. Investment (SIP)

    500

  • AMFI Code

    145455

  • ISIN Code

    INF740KA1LH9